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ABSTRACT: Subclinical ketosis (SCK) and 
periparturient diseases considerably account for 
economic and welfare losses in dairy cows. The 
majority of  scientific reports investigating the 
prevalence of  SCK and production diseases are 
based on empirical studies conducted in Western 
Europe and North America. The present study 
surveyed the prevalence of  SCK and produc-
tion-related clinical diseases in early lactating 
cows in various countries across the world other 
than those in North America and Western Europe. 
Twelve countries of  South and Central America 
(Argentina, Brazil, Chile, Colombia, Mexico), 
Africa (South Africa), Asia (Thailand, China), 
Eastern Europe (Russia, Ukraine), Australia, 
and New Zealand were assessed, and data from 
a total of  8,902 cows kept at 541 commercial 
dairy farms were obtained. A minimum of  five 
cows per farm were blood sampled and exam-
ined once after parturition up to day 21 of  lacta-
tion. Blood concentration of  β-hydroxybutyrate 
was measured (threshold for SCK: 1.2 mmol/L), 
and the presence of  production-related diseases 
such as milk fever, retained placenta, mastitis, 
metritis, displaced abomasum, lameness, and 
clinical ketosis was recorded. More than 95% of 
all cows were examined in their second week of 
lactation. Across all investigated countries, the 
SCK prevalence was 24.1%, ranging from 8.3% 
up to 40.1%. The prevalence of  production-re-
lated diseases detected during the first 21 d of 
lactation was relatively low (<5%). Calculated 
odds ratios did not indicate an elevated risk for 
production diseases in cows with SCK. Despite 
differences in production systems across coun-
tries and variation between individual farms 
within a region, the present study data on SCK 
prevalence align with observations in Western 
European and North American dairy herds. 
At the very early stage of  sampling and clinical 
examination for detection of  SCK, it cannot be 
excluded that certain production diseases such 
as displaced abomasum, lameness, and mastitis 
have developed later.
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INTRODUCTION
At the onset of lactation, dairy cows experience 
a marked metabolic load due to the prevailing neg-
ative energy balance, which makes them susceptible 
toward infectious and metabolic diseases (Gross 
et al., 2011; Bruckmaier and Gross, 2017). Increased 
concentrations of circulating ketone bodies, pre-
dominantly β-hydroxybutyrate (BHBA), without 
the presence of clinical signs of ketosis are consid-
ered as subclinical ketosis (SCK; Duffield, 2000). 
The blood BHBA thresholds for SCK diagnosis 
in literature range between 1.2 and 1.4  mmol/L 
(LeBlanc, 2010; Rollin et  al., 2010; Suthar et  al., 
2013; Compton et  al., 2014; Garro et  al., 2014). 
Although symptoms of clinical ketosis (CK) such 
as reduced milk production, lethargy, and loss of 
appetite are commonly observed at greater con-
centrations of BHBA (>3.0 mmol/L), some cows, 
however, may be exposed to high BHBA concen-
trations without showing any clinical signs, whereas 
others develop ketosis characteristics already at 
reduced BHBA concentrations (Andersson, 1988; 
Bruckmaier and Gross, 2017; Zbinden et al., 2017).
Subclinical ketosis affects performance and is 
obviously related to an increased risk of produc-
tion-related diseases such as CK, displaced aboma-
sum (DA), retained placenta, and metritis (Duffield 
et  al., 2009; McArt et  al., 2012). Concomitantly, 
production efficiency decreases (e.g., lower milk 
production, poor fertility, and increased culling 
rates), which results in economic losses (Walsh et al., 
2007; Duffield et al., 2009; McArt et al., 2012, 2015; 
Rutherford et al., 2016). Serum BHBA concentra-
tions ≥ 1.2 mmol/L in the first week after calving 
were associated with a several-fold increased risk of 
subsequently developing DA and metritis, respec-
tively (Duffield et  al., 2009). Ospina et  al. (2010) 
found increased odds ratios (OR) of 4.9 for CK, 2.3 
for metritis, and 6.9 for DA when plasma BHBA 
concentrations exceeded a threshold of 1.0 mmol/L 
during days 3 to 14 postpartum. A negative impact 
of SCK on milk yield of early lactating cows was 
reported by several authors (Dohoo and Martin, 
1984; Duffield et  al., 2009; McArt et  al., 2012; 
Zbinden et  al., 2017). Furthermore, cows with 
BHBA concentrations greater than 1.0 mmol/L in 
the first week after calving were significantly less 
likely to be diagnosed pregnant after first insemi-
nation (Walsh et al., 2007). The economic impact 
of SCK is therefore indisputable, although exact 
figures quantifying the actual costs of SCK are dif-
ficult to collect. Based on an earlier investigation 
on Canadian dairy farms including more than 
2,600 cows, McLaren et al. (2006) estimated that a 
reduction of 1% in SCK incidence would amount 
to a saving of 584 USD per year. Recently, McArt 
et  al. (2015) calculated the average total costs of 
hyperketonemia (blood BHBA concentrations ≥ 
1.2 mmol/L) to be 289 USD per case diagnosed.
Prevalence of SCK in the existing literature 
ranges between 10% and 40% in early lactation with 
greatest values occurring within the first 3  wk of 
lactation (Dohoo and Martin, 1984; Oetzel, 2004; 
Duffield et al., 2009). Most of these studies, how-
ever, included only a small number of dairy herds 
and cows (mainly research stations) and were per-
formed in North America and Western Europe (e.g., 
Rollin et al., 2010; McArt et al., 2012; Suthar et al., 
2013; Compton et al., 2014; Garro et al., 2014).
The objective of the present study was to sur-
vey the prevalence of SCK and the concomitant 
occurrence of health disorders in early lactating 
dairy cows in various countries across the world 
other than those in North America and Western 
Europe. Dairy farms in 12 countries of South 
and Central America (Argentina, Brazil, Chile, 
Colombia, and Mexico), Africa (South Africa), 
Asia (Thailand, China), Eastern Europe (Russia, 
Ukraine), Australia, and New Zealand were investi-
gated. To our knowledge, this is the first large-scale 
approach to investigate the prevalence of SCK 
beyond Western Europe and North America.
MATERIALS AND METHODS
Animals and Sampling
All procedures in terms of blood sampling and 
veterinary examinations followed the animal care 
and welfare legislation criteria of the involved coun-
tries. The study was conducted from June 2011 to 
September 2013 at different commercial dairy farms 
in 12 different countries worldwide (Argentina, 
Australia, Brazil, Chile, China, Colombia, Mexico, 
New Zealand, Russia, South Africa, Thailand, and 
Ukraine). Breeds included were dairy breeds (e.g., 
predominantly Holstein-Friesian, Jersey), local 
crossbred lines (e.g., Girolondo in Brazil, Simmental 
× Red Steppe in Russia), and others (e.g., Simmental). 
Management systems varied from grazing systems to 
indoor housing of animals throughout the year. In 
total, 8,902 early lactating dairy cows housed on 541 
farms were evaluated. At least five randomly selected 
cows of a herd in early lactation (days 2 to 21 post-
partum [p.p.]) inconspicuous of obvious health dis-
orders and without any previous treatments were 
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clinically examined, and blood was sampled for diag-
nostic purposes and health monitoring during regu-
lar herd health management visits by veterinarians 
in the field. Each cow was only tested once, and no 
further restrictions in selection criteria such as parity 
number, breed, or performance were implied. In all 
cows, blood samples were taken from the coccygeal 
vein, and BHBA concentrations were directly deter-
mined on-site using a handheld meter (Precision 
Xceed, Abbott Diabetes Care Inc., Alameda, CA), 
which was previously validated for the use in cows 
(Iwersen et  al., 2009; Pineda and Cardoso, 2015). 
Concomitantly, each sampled cow was clinically 
examined for the presence of metabolic and infec-
tious health disorders (milk fever, retained placenta, 
DA, lameness, mastitis, metritis, and CK) following 
standardized diagnostic definitions (Table 1).
Statistical Analyses
Cows sampled between days 2 and 21 p.p. were 
categorized “SCK negative” if  blood BHBA con-
centrations were <1.2  mmol/L or “SCK positive” 
if  BHBA concentrations were ≥1.2  mmol/L. The 
prevalence of SCK was calculated as proportion of 
animals with BHBA concentrations ≥ 1.2 mmol/L 
relative to all investigated cows. Prevalence data 
were estimated at country and average global lev-
els. In addition, overall and country-specific prev-
alence of postpartum diseases was calculated. 
The occurrence of postpartum diseases in rela-
tion to SCK was evaluated by OR analyses using 
the statistical package TESTIMATE (version 6.5, 
idv-Data Analysis & Study Planning, Krailling, 
Germany) according to the following formula: 
OR = − −[ / ( )] / [ / ( )],p p p p1 1 2 21 1  where p1 indi-
cates the probability of postpartum diseases under 
SCK conditions and p2 the probability of postpar-
tum diseases under non-SCK conditions.
RESULTS
Data analyses were based on a total of 8,902 
dairy cows from 541 different commercial dairy 
farms. The number of farms investigated per coun-
try and their herd size ranged from 2 farms with 83 
cows in Thailand to 102 farms housing 2,989 cows 
in New Zealand. On average, cows of the present 
data set were in their third lactation (range of par-
ity number: 1 to 14, 26.9% primiparous and 73.1% 
multiparous dairy cows; Table  2). The majority 
(95.1%) of the cows was examined and sampled 
between days 7 and 15 p.p.
Concentration of Blood BHBA and SCK
Blood BHBA concentrations observed between 
days 2 and 21 p.p. were 1.0 ± 0.8 mmol/L, ranging 
from an average value of 0.7  mmol/L (Australia, 
Brazil, Colombia, and Russia) to 1.5  mmol/L 
(Ukraine). In two thirds of the investigated coun-
tries, mean BHBA concentrations were less than 
1.0  mmol/L (0.7 to 0.9  mmol/L), whereas in one 
third of the countries (namely, China, New Zealand, 
Thailand, and Ukraine) mean BHBA concentrations 
of 1.0 mmol/L and above were observed (Table 3). 
Table  1. Definitions used for disease diagnosis during veterinary examinations of dairy cows in early 
lactation
Postpartum 
disease Definition Reference
Milk fever Cow requires Ca injections due to hypocalcaemia, based on clinical signs  
such as muscular weakness or lying cow unable to rise.
Duffield et al. (1999); LeBlanc et al. (2002); 
DeGaris and Lean (2008)
Retained placenta Failure to pass placenta within 24 h after calving Duffield et al. (1999); LeBlanc et al. (2002)
Mastitis Visually abnormal milk appearance and/or changes in the appearance of the 
udder (inflammatory signs, swollen or hard quarters)
Duffield et al. (1999); LeBlanc et al. (2002); 
Pérez-Cabal et al. (2009)
Displaced 
abomasum
Presence of gas-filled abomasum on left or upper right flank, based on a  
characteristic “ping” sound at auscultation or percussion, confirmed by 
surgery
Duffield et al. (1999); LeBlanc et al. (2002
Lameness Abnormal findings during claw examinations (such as interdigital and digital 
dermatitis) and/or lameness with a locomotion score1 of ≥3 (scale of 1 to 5)
Duffield et al. (1999); LeBlanc et al. (2002); 
Thomsen et al. (2008)
Metritis Enlarged uterus and/or purulent, smelly uterine discharge associated with sys-
temic signs (fever2, inappetence/anorexia, inactivity, decreased milk yield)
Duffield et al. (1999); LeBlanc et al. (2002); 
Sheldon et al. (2006)
Clinical ketosis Decreased milk production, reduced feed intake or inappetence, reduced  
activity, positive blood, milk or urine ketone test, absence of displaced  
abomasum or other primary disease, ketone odor in breath or milk
Duffield et al. (1999); LeBlanc et al. (2002)
1Scale 1 to 5.
2Body temperature > 39.5 °C.
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Blood BHBA concentrations of 3.0  mmol/L and 
beyond during the first 21 d of lactation were 
predominately observed in China and Ukraine 
(Table  3). Overall, SCK (BHBA concentrations ≥ 
1.2  mmol/L) was diagnosed in 24.1% of all cows 
examined, ranging from 8.3% (Colombia) up to 
40.1% (New Zealand; Figure 1). In only 2 (Australia 
and Colombia) out of the 12 investigated coun-
tries, SCK prevalence on the participating farms 
was less than 10%. In four countries (Brazil, Chile, 
Mexico, Russia), SCK prevalence varied between 
10.7% and 14.8%, whereas in the remaining coun-
tries (Argentina, China, New Zealand, South Africa, 
Thailand, Ukraine), SCK prevalence was more than 
Table 3. Blood BHBA concentrations in early lactating dairy cows (2- to 21-d postpartum) in different 
countries and proportion of cows with highly elevated BHBA concentrations
BHBA1 concentration (mmol/L)
Cows with BHBA ≥ 
3.0 mmol/L
Country n Mean ± SD Range n %
Argentina 720 0.9 ± 0.9 0.1 to 6.2 36 5.0
Australia 208 0.7 ± 0.7 0.1 to 7.0 4 1.9
Brazil 159 0.7 ± 0.6 0.1 to 4.8 3 1.9
Chile 183 0.8 ± 0.7 0.0 to 4.6 3 1.6
China 404 1.2 ± 1.0 0.0 to 5.8 33 8.2
Colombia 791 0.7 ± 0.4 0.1 to 4.2 4 0.5
Mexico 2,060 0.8 ± 0.7 0.0 to 6.0 53 2.6
New Zealand 2,990 1.2 ± 0.7 0.0 to 8.0 101 3.4
Russia 764 0.7 ± 0.7 0.1 to 6.4 18 2.4
South Africa 376 0.9 ± 1.0 0.1 to 7.2 20 5.3
Thailand 83 1.0 ± 0.8 0.1 to 5.8 2 2.4
Ukraine 164 1.5 ± 1.5 0.0 to 6.7 22 13.4
Overall 8,902 1.0 ± 0.8 0.0 to 8.0 299 3.4
1BHBA = β-hydroxybutyrate.
Table 2. Information on animals and farms of the different participating countries in the present study
Country Farms (n) Cows (n) Percentage of cows Cattle breed Housing
Parity  
number1
Milk yield (kg/d 
per cow)
Primiparous Multiparous
Argentina 27 720 26.0 74.0 Holstein-Friesian Pasture and 
indoors
2.8 ± 1.8 28.5
Australia 22 208 15.0 85.0 Holstein-Friesian Pasture 3.4 ± 2.0 18.4
Brazil 26 159 35.5 64.5 50% Holstein- 
Friesian, 50% others 
(Girolondo, Gyr, Brown 
Swiss)
Pasture and 
indoors
2.5 ± 1.7 13 to 30
Chile 17 183 24.6 75.4 Holstein-Friesian Pasture and 
indoors
2.6 ± 1.3 23.0
China 41 404 63.1 36.9 Holstein-Friesian Indoors 1.3 ± 1.5 25 to 35
Colombia 79 791 27.1 72.9 Holstein-Friesian, 
Brahman, Brahman 
crossbred
Pasture 2.9 ± 1.8 17 to 21
Mexico 63 2,060 37.6 62.4 Holstein-Friesian or HF 
crossbred
Pasture and 
indoors
2.3 ± 1.7 18 to 22
New Zealand 102 2,989 13.7 86.3 Holstein-Friesian, Jersey, 
HF/Jersey crossbred
Pasture 4.0 ± 2.4 13 to 19
Russia 77 764 39.3 60.7 Holstein-Friesian, 
Simmental, Red Steppe
Indoors 2.2 ± 1.2 13 to 23
South Africa 54 377 18.1 81.9 Holstein-Friesian Pasture 3.3 ± 1.9 20 to 25
Thailand 2 83 32.5 67.5 88% Holstein-Friesian Indoors 3.3 ± 2.3 12 to 20
Ukraine 31 164 21.3 78.7 50% Holstein-Friesian, 
50% others
Indoors 2.6 ± 1.3 13 to 25
Overall 541 8,902 26.9 73.1 3.0 ± 2.1
1Data are expressed as mean ± SD.
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15% (between 17.0% and 40.1%). More than 80% of 
all cows diagnosed SCK were multiparous. In con-
trast, we observed SCK occurring more frequently 
(P  <  0.05) in primiparous cows in three countries 
(Chile, South Africa, and Ukraine; Figure 2).
Prevalence of Concomitant Production Diseases 
and Their Association With SCK
The overall prevalence of production diseases 
was 4.3% for milk fever, 4.0% for retained pla-
centa, 3.4% for mastitis, 1.7% for lameness, and 
5.3% for metritis (Table  4). Displaced abomasum 
and CK showed a very low prevalence (0.3% and 
0.7%, respectively). During the first 21-d p.p., DA 
was not seen in 50% (6/12) of the investigated coun-
tries and CK was diagnosed in only 7 out of 12 
countries. We further investigated the relationship 
of SCK with the concomitant presence of health 
disorders in early lactation by performing an OR 
analysis. However, due to the generally low prev-
alence of diseases, OR were <1, and an increased 
risk of disease in association with SCK could not 
be identified in the present study (data not shown). 
The greatest OR was calculated for CK as cows 
diagnosed SCK had a 1.062 greater probability of 
having subsequently CK.
DISCUSSION
In the last three decades, research results address-
ing SCK and periparturient diseases represented 
primarily published data from the United States, 
Canada, and Western Europe (McArt et  al., 2012; 
Suthar et  al., 2013; Raboisson et  al., 2014). The 
majority of reports usually based on investigations 
conducted in regional and small-sized dairy farms of 
individual countries (Oetzel, 2004; McLaren et al., 
2006; Ospina et al., 2010; Garro et al., 2014). Studies 
involving a greater number of animals and covering 
Figure 1. Prevalence of subclinical ketosis (SCK, blood β-hydroxybutyrate concentrations ≥ 1.2 mmol/L) in early lactating dairy cows studied 
in 12 countries worldwide.
Figure 2. Occurrence of subclinical ketosis (SCK; blood β-hydroxybutyrate concentrations ≥ 1.2 mmol/L) in primiparous and multiparous cows 
during early lactation in different countries worldwide.
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wider geographic areas were presented earlier by 
Chapinal et al. (2011) and Suthar et al. (2013), but 
still considered only SCK occurrence within Europe 
and the United States, respectively. Different study 
designs and scopes (such as pre- or postpartum 
reclassification of animals, herd- or cow-level investi-
gations, sampling of blood, milk or urine, and defin-
ing SCK at various BHBA thresholds) do not always 
allow a straightforward comparison of literature 
data across farms, regions, and countries, as recently 
described in a meta-analysis evaluating 23 SCK pub-
lications by Raboisson et  al. (2014). Furthermore, 
data on global SCK prevalence obtained by a stand-
ardized protocol for sampling and defining SCK are 
scarce. Therefore, we have investigated the preva-
lence of SCK and typical production-related disor-
ders in early lactating dairy cows in various countries 
across the world other than those in North America 
and Western Europe. By using the same validated 
tool for on-site BHBA testing in all cows, diagnosing 
SCK at the generally accepted blood BHBA cut-off  
concentration of 1.2  mmol/L, and sampling cows 
in the very early lactation (days 2 to 21 p.p.) make 
the results presented here comparable to studies per-
formed in other countries. Many countries world-
wide refer to the thresholds for classification of SCK 
as obtained in North America and Western Europe. 
Although individual differences in setting thresholds 
might exist, the prominent threshold of 1.2 mmol/L 
allows an estimation of consequences for health and 
animal performance.
The overall SCK prevalence of the present 
survey was in a comparable range to observations 
from a European evaluation of Suthar et al. (2013). 
In addition, the variation in the global SCK rates 
presented here is considerable (approximately 8% 
to 40%) and is similar to findings reported for the 
United States and Europe (McArt et  al., 2012; 
Suthar et al., 2013; Garro et al., 2014). The major-
ity of our investigated cows with SCK were mul-
tiparous confirming the assumptions that the risk 
of developing SCK increases with parity number 
as milk production rises concomitantly (Duffield 
et al., 1997). Based on an analysis of a variety of 
publications, Oetzel (2004) considered a prevalence 
rate of 15% representative for SCK in dairy herds 
but emphasized to consider an SCK prevalence of 
10% already as an alert level. In general, the SCK 
incidence in our investigations was similar to the 
range of findings in Western Europe and North 
America. In the present study, only 2 out of 12 coun-
tries (Australia and Colombia) had an average SCK 
prevalence of less than 10%, whereas the remaining 
countries had greater rates. Four countries (China, T
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New Zealand, Ukraine, and Thailand) revealed 
even SCK rates up to 40%. However, this does not 
exclude that SCK may also occur at greater rates 
in the countries with low SCK prevalence in the 
present study, which might be attributed to the 
random selection of farms and animals. In gen-
eral, SCK in early lactating dairy cows is globally 
present. Further explanations for differences in 
SCK incidence might be greater milk production 
in some countries resulting in a more negative 
energy balance, geographic and regional differences 
of management, and dairy cow feeding as well as 
individual cow variation. The greatest average SCK 
prevalence of all countries was observed in New 
Zealand. One explanation might be that dairy cows 
in New Zealand are mostly kept under extensive pas-
ture-based production conditions with low or even 
zero concentrate supplementation (Compton et al., 
2014). Along with the genetic progress in dairy cow 
breeding, milk production in export-oriented coun-
tries such as New Zealand probably increased and 
aggravated the energy deficiency in early lactating 
cows (Capper et al., 2009; Bruckmaier and Gross, 
2017). In another study, Compton et  al. (2014) 
observed a SCK prevalence of approximately 17% 
in New Zealand dairy cows, which would be still in 
the upper range when compared with the present 
evaluations. The difference just implies the possible 
variation due to the selection of farms and animals.
Interestingly, the occurrence of  postpartum 
diseases in the present study was much lower com-
pared with literature reports. Our observations 
on average prevalence rates of  retained placenta, 
mastitis, lameness, and metritis were approxi-
mately half  of  the values reported in a European 
study by Suthar et al. (2013). At first sight, these 
results were surprising considering the fact that 
SCK prevalence rates of  this investigation were in 
agreement with other reports published. The cows 
diagnosed SCK in the present study did obviously 
not develop health disorders at this early sampling 
stage. However, results of  the concomitant pres-
ence of  SCK and further production diseases are 
inconsistent. Although we observed the greatest 
SCK prevalence on farms in New Zealand, post-
partum diseases occurred only at less than 1% 
in cows diagnosed SCK. On the other hand, the 
SCK prevalence data in Russia were only moder-
ately increased (14.1%), but many health disorders 
were diagnosed at the same time (milk fever 37.4%, 
retained placenta 17.0%, mastitis 14.9%, lameness 
10.5%). In a recent study by Zbinden et al. (2017), 
high-yielding cows fed only herbage showed 
blood BHBA concentrations approaching that 
representative for CK, however, not necessarily 
followed by the occurrence of  diseases. Irrespective 
of  the concomitant presence of  production dis-
eases in cows with SCK, elevated BHBA concen-
trations ≥ 1.2  mmol/L undoubtedly increase the 
risk of  subsequently developing further health 
disorders (Duffield et  al., 2009; Ospina et  al., 
2010) and simultaneously reduced performance 
in terms of  milk yield and reproduction (Dohoo 
and Martin, 1984; Walsh et  al., 2007; Duffield 
et al., 2009; McArt et al., 2012). Management and 
environmental conditions are crucial factors that 
affect the ability of  cows to cope successfully with 
the imposed metabolic load. These circumstances 
cannot be effectively recorded in a field study like 
the present one. Furthermore, one might specu-
late on regional differences in terms of  breed and 
feeding system affecting the development of  health 
disorders. The occurrence of  DA was reported to 
be relatively rare in dairy cattle in New Zealand 
and Australia (Jubb et al., 1991; Compton et al., 
2014), which is assumed to be associated with 
the predominantly extensive farming on pasture 
where important risk factors for DA such as low 
locomotion activity are not important. However, 
prevalence of  DA concomitant with SCK in the 
present study was, in particular, low in countries 
with a more intensive milk production in confined 
housing systems (e.g., China, Russia, Thailand, 
and Ukraine). Similar observations were made for 
mastitis and the occurrence of  lameness. Although 
lameness may also occur in cattle on pasture, it 
appears to be less frequent and to be usually based 
on a different etiology (Chesterton et  al., 1989; 
Laven and Holmes, 2008). In contrast, we observed 
that mastitis prevalence in cows with SCK can be 
elevated independently if  cows were kept on pas-
ture or indoors.
In conclusion, findings of the present study 
showed that SCK in dairy cows is a global issue and 
can be observed at various rates in many countries 
over the world. Possibly due to the diagnosis of SCK 
and clinical examination at a very early stage of lacta-
tion, concomitant postpartum diseases in cows diag-
nosed for SCK have not yet developed at this stage. 
An appropriate management is crucial for avoiding 
a deterioration of animals’ metabolic status with the 
associated negative impacts on health and perfor-
mance. The results of the present study support the 
hypothesis that the association between SCK and 
postpartum diseases is complex and that based on 
an occasional single determination of blood BHBA 
concentrations alone, a reliable and robust prediction 
of further production diseases is not possible.
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